Long-term risk of cancer development in adult patients with idiopathic aplastic anemia after treatment with anti-thymocyte globulin.
作者信息
van der Hem Joost G K, de Wreede Liesbeth C, Brand Anneke, Veelken Hendrik, Falkenburg J H Frederik, Halkes Constantijn J M
机构信息
Department of Hematology, LUMC, Leiden, The Netherlands.
Department of Medical Statistics and Bioinformatics, LUMC, Leiden, The Netherlands.
出版信息
Haematologica. 2017 Oct;102(10):e382-e383. doi: 10.3324/haematol.2017.171215. Epub 2017 Jul 13.
Abstract
摘要
相似文献
1
Long-term risk of cancer development in adult patients with idiopathic aplastic anemia after treatment with anti-thymocyte globulin.接受抗胸腺细胞球蛋白治疗的成人特发性再生障碍性贫血患者发生癌症的长期风险。
Haematologica. 2017 Oct;102(10):e382-e383. doi: 10.3324/haematol.2017.171215. Epub 2017 Jul 13.
2
Successful desensitization to antithymocyte globulin in a child with aplastic anemia.
Am J Health Syst Pharm. 2006 Sep 1;63(17):1633-6. doi: 10.2146/ajhp050422.
3
[Curative effect of antithymocyte globulin for aplastic anemia in 8 children].
Zhongguo Dang Dai Er Ke Za Zhi. 2011 Sep;13(9):760-2.
4
Merkel cell carcinoma developing after antithymocyte globulin and cyclosporine therapy for aplastic anemia.再生障碍性贫血患者在接受抗胸腺细胞球蛋白和环孢素治疗后发生默克尔细胞癌。
Anticancer Drugs. 2003 Mar;14(3):251-3. doi: 10.1097/00001813-200303000-00010.
5
[Side effects and strategy in treating pediatric patients with aplastic anemia with anti-thymocyte globulin].[抗胸腺细胞球蛋白治疗小儿再生障碍性贫血的副作用及策略]
Zhonghua Er Ke Za Zhi. 2006 May;44(5):383-4.
6
[Moderate aplastic anemia associated with Crohn's disease during antithymocyte globulin treatment].[抗胸腺细胞球蛋白治疗期间与克罗恩病相关的中度再生障碍性贫血]
Rinsho Ketsueki. 1999 Oct;40(10):1105-9.
7
Long-term follow-up study of porcine anti-human thymocyte immunoglobulin therapy combined with cyclosporine for severe aplastic anemia.猪抗人胸腺细胞免疫球蛋白联合环孢素治疗重型再生障碍性贫血的长期随访研究
Eur J Haematol. 2016 Mar;96(3):291-6. doi: 10.1111/ejh.12590. Epub 2015 Jun 22.
8
Littoral cell angioma of the spleen in a patient with severe aplastic anaemia.一名重症再生障碍性贫血患者的脾脏边缘区细胞血管瘤。
Haematologica. 2003 Nov;88(11):ECR33.
9
A Rare Case of Hemolysis Following Antithymocyte Globulin in a Pediatric Patient With Aplastic Anemia Receiving Immunosuppressive Therapy.一名接受免疫抑制治疗的再生障碍性贫血患儿使用抗胸腺细胞球蛋白后发生溶血的罕见病例。
J Pediatr Hematol Oncol. 2024 Aug 1;46(6):e480. doi: 10.1097/MPH.0000000000002902. Epub 2024 Jul 3.
10
Liver function abnormality following treatment with antithymocyte globulin for aplastic anaemia.再生障碍性贫血患者接受抗胸腺细胞球蛋白治疗后出现肝功能异常。
Bone Marrow Transplant. 1997 Feb;19(3):249-51. doi: 10.1038/sj.bmt.1700653.
引用本文的文献
1
Quality of life after immune suppressive therapy in aplastic anemia.再生障碍性贫血免疫抑制治疗后的生活质量。
Ann Hematol. 2024 Jun;103(6):2113-2121. doi: 10.1007/s00277-024-05731-x. Epub 2024 Apr 5.
2
Aplastic Anemia as a Roadmap for Bone Marrow Failure: An Overview and a Clinical Workflow.再生障碍性贫血作为骨髓衰竭的路线图：概述和临床工作流程。
Int J Mol Sci. 2022 Oct 4;23(19):11765. doi: 10.3390/ijms231911765.
3
Chinese Herbal Medicine Therapy Reduces the Risks of Overall and Anemia-Related Mortalities in Patients With Aplastic Anemia: A Nationwide Retrospective Study in Taiwan.中药疗法降低再生障碍性贫血患者的总体死亡风险和贫血相关死亡风险：台湾一项全国性回顾性研究
Front Pharmacol. 2021 Oct 8;12:730776. doi: 10.3389/fphar.2021.730776. eCollection 2021.
本文引用的文献
1
Suggestions on the use of statistical methodologies in studies of the European Group for Blood and Marrow Transplantation.关于在欧洲血液和骨髓移植学会研究中使用统计方法学的建议。
Bone Marrow Transplant. 2013 Mar;48 Suppl 1:S1-37. doi: 10.1038/bmt.2012.282.
2
Late effects among pediatric patients followed for nearly 4 decades after transplantation for severe aplastic anemia.近 40 年随访的重型再生障碍性贫血患儿移植后晚期效应。
Blood. 2011 Aug 4;118(5):1421-8. doi: 10.1182/blood-2011-02-334953. Epub 2011 Jun 7.
3
Antithymocyte globulin with or without cyclosporin A: 11-year follow-up of a randomized trial comparing treatments of aplastic anemia.抗胸腺细胞球蛋白联合或不联合环孢素A：再生障碍性贫血治疗比较随机试验的11年随访
Blood. 2003 Feb 15;101(4):1236-42. doi: 10.1182/blood-2002-04-1134. Epub 2002 Oct 10.
4
Malignant neoplasms in long-term survivors of bone marrow transplantation. Late Effects Working Party of the European Cooperative Group for Blood and Marrow Transplantation and the European Late Effect Project Group.骨髓移植长期存活者中的恶性肿瘤。欧洲血液和骨髓移植合作组晚期效应工作组及欧洲晚期效应项目组
Ann Intern Med. 1999 Nov 16;131(10):738-44. doi: 10.7326/0003-4819-131-10-199911160-00004.
5
De novo malignancy emerges as a major cause of morbidity and late failure in renal transplantation.新发恶性肿瘤已成为肾移植发病和晚期移植失败的主要原因。
Transplant Proc. 1993 Feb;25(1 Pt 2):1383-4.
6
Malignant tumors occurring after treatment of aplastic anemia. European Bone Marrow Transplantation-Severe Aplastic Anaemia Working Party.再生障碍性贫血治疗后发生的恶性肿瘤。欧洲骨髓移植-重型再生障碍性贫血工作组。
N Engl J Med. 1993 Oct 14;329(16):1152-7. doi: 10.1056/NEJM199310143291603.
7
Late clonal complications in severe aplastic anemia.重型再生障碍性贫血的晚期克隆性并发症
Leuk Lymphoma. 1994 Jan;12(3-4):167-75. doi: 10.3109/10428199409059587.
Zotero 插件